Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Satisfaction × Aftercare × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Skin Carcinoma 1 Patient Satisfaction 1 Melanoma 1 Hematologic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 3 delta 24-sterol reductase 2 Urinary Diversion 2 Surgical Procedures, Operative 2 Propofol 2 daratumumab 1 Vascular Access Devices 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Pilot Projects 1 Patient Transfer 1 Parapsychology 1 Music Therapy 1 Midazolam 1 Mastectomy, Segmental 1 Lidocaine 1 Imiquimod 1 Ibuprofen 1 Fentanyl 1 Exercise 1 Drainage 1 Cystectomy 1 Control Groups 1 Colonoscopy 1 Bandages, Hydrocolloid 1 Ambulatory Care 1 Alfentanil 1 Aftercare 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03456167 2021-04-21

ERAS-OncoRe

Alberta Health Services, Calgary

Phase NA Completed

Breast Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡